Prioritizing the treatment of underlying inflammation may lead to better outcomes for patients with dry eye disease, according to speakers at the virtual OIS Dry Eye Innovation Showcase.
“There are many components to dry eye disease. It is very complex, and I like the fact that it’s not a cookie cutter approach. Every patient has a different nuanced version of this multifactorial disease,” Cynthia Matossian, MD, FACS, said. “But at the kernel of it, there is an inflammatory process and there’s a dysregulation of the homeostasis.”
To treat dry eye (Read more...)
Uncategorized